Recent Publications
Stamova B, Tian Y, Jickling G, Bushnell C, Zhan X, Liu D, Ander BP, Verro P, Patel V, Pevec WC, Hedayati N, Dawson DL, Jauch EC, Pancioli A, Broderick JP, Sharp FR.
The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke. 2012;43(2):326-334.
Tian Y, Stamova B, Jickling GC, Xu H, Liu D, Ander BP, Bushnell C, Zhan X, Turner RJ, Davis RR, Verro P, Pevec WC, Hedayati N, Dawson DL, Khoury J, Jauch EC, Pancioli A, Broderick JP, Sharp FR.
Y chromosome gene expression in the blood of male patients with ischemic stroke compared with male controls. Gend Med. 2012;9(2):68-75.
Tian Y, Stamova B, Jickling GC, Liu D, Ander BP, Bushnell C, Zhan X, Davis RR, Verro P, Pevec WC, Hedayati N, Dawson DL, Khoury J, Jauch EC, Pancioli A, Broderick JP, Sharp FR.
Effects of gender on gene expression in the blood of ischemic stroke patients. J Cereb Blood Flow Metab. 2012;32(5):780-791.
Bushnell C, Cox M, Hawes J, Zhao X, Olson DW, Peterson E, Zorowitz R. Patterns of rehabilitation service use following acute stroke and its association with rehospitalization: the AVAIL Registry [abstract]. Stroke. 2011;42(3):e337-e338.
Olson D, Bushnell C, Cox M, Zimmer LO, Pan W, Sacco R, Fonarow GC, Zorowitz R, LaBresch KA, Schwamm LH, et al. Death and rehospitalization following hospitalization for stroke/TIA: one year findings from AVAIL [abstract]. Stroke. 2011;42(3):E80.
Olson D, Bushnell C, Cox M, Peterson E. Patterns of antihypertensive medication use and persistence in stroke patients [abstract]. Stroke. 2011;42(3):e243-e244.
Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, et al.
Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77(12):1182-1190.
Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Bushnell CD, et al.
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 2011;124(20):2233-2242.
Zhan X, Jickling GC, Tian Y, Stamova B, Xu H, Ander BP, Turner RJ, Mesias M, Verro P, Bushnell C, Johnston SC, Sharp FR.
Transient ischemic attacks characterized by RNA profiles in blood. Neurology. 2011;77(19):1718-1724.
James SK, Storey RF, Bushnell C, Horrow J, Husted S, Mahaffey KW, Maya J, Becker RC. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and history of stroke or transient ischemic accident: results from the Platelet Inhibition and Patient Outcomes Trial [abstract]. Circulation. 2011;124(21 Suppl):A15029.
Bushnell C, Archer D, Brosnihan B. Vascular cell adhesion molecule-1 (VCAM-1) levels in patients at risk for stroke: the impact of gender and risk factor load [abstract]. Stroke. 2010;41(4):E302.
Stamova B, Xu H, Jickling G, Bushnell C, Tian Y, Ander BP, Zhan X, Liu D, Turner R, Adamczyk P, et al.
Gene expression profiling of blood for the prediction of ischemic stroke. Stroke. 2010;41(10):2171-2177.
D'Onofrio G, Jauch E, Jagoda A, Allen MH, Anglin D, Barsan WG, Berger RP, Bobrow BJ, Boudreaux ED, Bushnell C, et al.
NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies. Ann Emerg Med. 2010;56(5):551-564.
Bushnell CD, Zimmer CO, Pan W, Olson DM, Zhao X, Meteleva T, Schwamm L, Ovbiagele B, Williams L, LaBresh KA, et al.
Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67(12):1456-1463.
Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Channing NC, Harding T, Drew L, Zhao X, Peterson E.
The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J. 2009;157(3):428-435.e2.
Bushnell C, Schneck M, Zhao X, Ralph S, Ovbiagele B, Schwamm L, Peterson E. Persistent use of antiplatelet therapies after stroke: does age matter? [abstract]. Stroke. 2009;40(4):e270.
Rudisill M, Parks ME, Tegeler C, Bushnell C. Education for stroke survivors: extending quality improvement 'Beyond the Hospital' [abstract]. Stroke. 2009;40(4):e138.
Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, Mysiw WJ, Maldjian JA, Melhem ER, Resnick SM.
Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009;64(12):1243-1250.
Bushnell C, Tindle H, Espeland M, Jamillo S, Melhem E, Resnick S. Regional brain and ischemic lesion volumes in women with cognitive impairment following exposure to conjugated equine estrogen therapies (CEE): the Women's Health Initiative Magnetic Resonance Imaging Study (WHIMS-MRI) [abstract]. Neurology. 2009;72(11 Suppl 3):A171-A172.
Bushnell C, Alberts M, Frankel M, Goldstein LB, Gorelick P, Johnston SC, Kidwell C, Schwamm L, Williams L, Peterson E. Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL): identifying facilitators of adherence to stroke prevention medications [abstract]. Stroke. 2008;39(2):556.
Bushnell C, Ortel T, Goldstein L. Elevated levels of thrombin-antithrombin (TAT) are associated with greater stroke severity in African American but not white women [abstract]. Stroke. 2008;39(2):561.
Bushnell C, Fagan S, Frankel M, Goldstein LB, Gorelick P, Johnston SC, Sacco R, Schwamm L, Williams L, Zorowitz R, et al. Gender differences in secondary prevention medication persistence following stroke [abstract]. Circulation. 2008;117(21):e418.
Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L.
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7(10):915-926.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.